Skip to main content

GEODE CAPITAL MANAGEMENT, LLC

Position in ELVN — Enliven Therapeutics, Inc.

CIK 1214717 BOSTON, MA

Position in ELVN

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$71,415,501
+$29,611,838 QoQ
Shares Held
1,407,202
+32.0% QoQ
Ownership
1.92%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#13
of 210 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ELVN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $21,877,569,550 across 521 Biotechnology names. ELVN ranks #64 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ELVN

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $71,415,501 1,407,202
2026-03-31 $41,803,663 1,066,420
2025-12-31 $16,150,318 1,048,722
2025-09-30 $22,210,216 1,085,013
2025-06-30 $17,708,024 882,753
2025-03-31 $16,121,323 819,173
2024-12-31 $17,161,154 762,718
2024-09-30 $19,160,311 750,208
2024-06-30 $15,947,570 682,395
2024-03-31 $8,363,271 475,456
2023-12-31 $6,430,852 464,657
2023-09-30 $5,914,397 432,972
2023-06-30 $8,458,802 414,444
2023-03-31 $774,997 35,388